Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer

by O I Kit, L Y Vladimirova, N A Abramova, A E Storozhakova, I L Popova, N M Tikhanovskaya, A A Lyaynova, L A Ryadinskaya
Published 2017-06-01

Trastuzumab emtansine of the treatment of HER2-positive breast cancer with brain metatases

by L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, M. O. Ezhova, V. S. Myagkova, L. K. Strakhova
Published 2020-12-01

Nab-paclitaxel monotherapy in patients with metastatic breast cancer with visceral crisis: evaluation of efficacy and tolerability in clinical practice

by L. Yu. Vladimirova, K. A. Novoselova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, L. A. Ryadinskaya, A. A. Lyanova, M. O. Ezhova, M. A. Teplyakova, A. A. Tishina, E. V. Prikhodko
Published 2019-06-01

Fulvestrant in treatment for metastatic breast cancer

by L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, A. E. Storozhakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. L’yanova, L. A. Ryadinskaya, M. O. Ezhova, M. A. Teplyakova, L. K. Strakhov
Published 2019-12-01

Study of EGFR expression in tumor tissue in patients with locally advanced oral cavity cancer receiving cetuximab therapy

by A. A. Lyanova, L. Yu. Vladimirova, E. P. Ulianova, A. E. Storozhakova, N. A. Abramova, I. L. Popova, M. A. Teplyakova, N. M. Tikhanovskaya, V. S. Myagkova, K. A. Novoselova, L. A. Ryadinskaya, L. K. Strakhova, E. A. Kalabanova
Published 2020-07-01

Some aspects of nivolumab administration in treatment for metastatic melanoma (clinical cases)

by L. Yu. Vladimirova, A. Eh. Storozhakova, I. L. Popova, S. N. Kabanov, N. A. Abramova, M. A. Teplyakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. Lyanova, L. A. Ryadinskaya, V. S. Myagkova, F. V. Alieva, E. A. Kalabanova, Ya. V. Svetitskaya, N. Yu. Samaneva, A. V. Tishina
Published 2021-08-01

EXPERIENCE OF USING PERTUZUMAB IN ANTICANCER THERAPY FOR HER2-POSITIVE BREAST CANCER

by O. I. Kit, L. Yu. Vladimirova, E. A. Kalabanova, A. E. Storozhakova, S. N. Kabanov, T. A. Snezhko, I. S. Mitashok, Ya. V. Svetitskaya, N. Yu. Samaneva, I. S. Kornilova, Yu. V. Przhedetskiy, V. V. Pozdnyakova, N. A. Abramova, I. L. Popova, N. M. Tikhanovskaya, A. A. Lyanova, K. A. Novoselova, L. A. Ryadinskaya
Published 2021-05-01

Vinflunine as second-line therapy for advanced urothelial carcinoma: Russian observational study

by M. I. Volkova, V. A. Chernyaev, V. B. Matveev, B. Ya. Alekseev, K. M. Nyushko, L. V. Bolotina, A. L. Kornietskaya, A. A. Paichadze, S. Ch. Maykoparova, L. A. Ryadinskaya, S. N. Kabanov, A. E. Storozhakova, N. Yu. Samaneva, A. V. Shcherbinin, S. A. Varlamov, I. S. Varlamov, E. I. Kopyl’tsov, A. A. Lebedinets, M. V. Odintsova, S. S. Kolesnikov, E. V. Karabina
Published 2017-09-01

The efficacy and safety of vinflunine in second-line therapy of patients with disseminated transitional cell carcinoma of the urinary tract in clinical practice

by M. I. Volkova, V. A. Chernyaev, V. B. Matveev, B. Ya. Alekseev, K. M. Nyushko, L. V. Bolotina, A. L. Kornietskaya, A. A. Paichadze, S. Ch. Maikoparova, L. A. Ryadinskaya, S. N. Kabanov, A. E. Storozhakova, N. Yu. Samaneva, A. V. Shcherbinin, S. A. Varlamov, I. S. Varlamov, E. I. Kopyltsov, A. A. Lebedinets, M. V. Odintsova, S. S. Kolesnikov, E. V. Karabina
Published 2016-09-01